206 related articles for article (PubMed ID: 8546457)
21. Economic analysis of cancer treatment costs: another tool for oncology managers.
Chirikos TN; Ruckdeschel JC; Krischer JP
J Oncol Manag; 2001; 10(3):11-7. PubMed ID: 11548179
[TBL] [Abstract][Full Text] [Related]
22. Comparative effectiveness research in oncology: the need for clarity, transparency and vision.
Lyman GH
Cancer Invest; 2009 Jul; 27(6):593-7. PubMed ID: 19557579
[No Abstract] [Full Text] [Related]
23. How should we pay the piper when he's calling the tune? On the long-term affordability of cancer care in the United States.
Ramsey SD
J Clin Oncol; 2007 Jan; 25(2):175-9. PubMed ID: 17210936
[No Abstract] [Full Text] [Related]
24. Cost of cancer care: the patient perspective.
Kim P
J Clin Oncol; 2007 Jan; 25(2):228-32. PubMed ID: 17210945
[TBL] [Abstract][Full Text] [Related]
25. [Evaluation of cancer therapy from the perspective of a statutory health insurance].
Rebscher H; Schellhammer S; Kopp T; Scharnetzky E
Urologe A; 2011 Dec; 50(12):1584-90. PubMed ID: 22159704
[TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness analyses in gynecologic oncology: methodological quality and trends.
Manuel MR; Chen LM; Caughey AB; Subak LL
Gynecol Oncol; 2004 Apr; 93(1):1-8. PubMed ID: 15047206
[TBL] [Abstract][Full Text] [Related]
27. Taking quality of life into account in health economic analyses.
Weeks J
J Natl Cancer Inst Monogr; 1996; (20):23-7. PubMed ID: 8750463
[TBL] [Abstract][Full Text] [Related]
28. Many new cancer drugs in the United Kingdom are facing negative NICE rulings.
Low E;
J Clin Oncol; 2007 Jun; 25(18):2635-6; author reply 2637-8. PubMed ID: 17577049
[No Abstract] [Full Text] [Related]
29. Clinical Cancer Advances 2009: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
Petrelli NJ; Winer EP; Brahmer J; Dubey S; Smith S; Thomas C; Vahdat LT; Obel J; Vogelzang N; Markman M; Sweetenham JW; Pfister D; Kris MG; Schuchter LM; Sawaya R; Raghavan D; Ganz PA; Kramer B
J Clin Oncol; 2009 Dec; 27(35):6052-69. PubMed ID: 19901123
[No Abstract] [Full Text] [Related]
30. Efficacy and medical cost offset of psychosocial interventions in cancer care: making the case for economic analyses.
Carlson LE; Bultz BD
Psychooncology; 2004 Dec; 13(12):837-49; discussion 850-6. PubMed ID: 15578622
[TBL] [Abstract][Full Text] [Related]
31. [Cost-effectiveness of cancer therapy].
Hisashige A
Gan To Kagaku Ryoho; 2000 Aug; 27(9):1347-53. PubMed ID: 10969588
[TBL] [Abstract][Full Text] [Related]
32. A time of change in medical oncology. Problems created by the lack of coherence in Australia's health care system.
Lowenthal RM
Med J Aust; 1992 Jul; 157(1):28-30. PubMed ID: 1640887
[No Abstract] [Full Text] [Related]
33. [Economic limits in oncology].
Hellriegel KP
Z Arztl Fortbild Qualitatssich; 2000 Dec; 94(10):833-6. PubMed ID: 11190919
[TBL] [Abstract][Full Text] [Related]
34. A conversation with Lee N. Newcomer, MD, MHA. Payments with purpose. Interview by John Marcille.
Newcomer LN
Manag Care; 2011 Dec; 20(12):36-40. PubMed ID: 22259875
[No Abstract] [Full Text] [Related]
35. Cancer Quality Alliance: Blueprint for a better cancer care system.
Rose C; Stovall E; Ganz PA; Desch C; Hewitt M
CA Cancer J Clin; 2008; 58(5):266-92. PubMed ID: 18768677
[TBL] [Abstract][Full Text] [Related]
36. Economic cost analysis in cancer management and its relevance today.
Sharma K; Das S; Mukhopadhyay A; Rath GK; Mohanti BK
Indian J Cancer; 2009; 46(3):184-9. PubMed ID: 19574668
[TBL] [Abstract][Full Text] [Related]
37. [Interest in and limitations of economic assessment applied to the evaluation of medical strategies: examples in oncological hematology].
Moatti JP
Therapie; 2001; 56(2):135-8. PubMed ID: 11471364
[TBL] [Abstract][Full Text] [Related]
38. Cost effectiveness of myeloid growth factors in cancer chemotherapy.
Lyman GH; Kuderer NM
Curr Hematol Rep; 2003 Nov; 2(6):471-9. PubMed ID: 14561391
[TBL] [Abstract][Full Text] [Related]
39. Not at any cost: organizations help patients cope with costs of cancer care.
Printz C
Cancer; 2011 Mar; 117(5):879. PubMed ID: 21351079
[No Abstract] [Full Text] [Related]
40. [The "Plan Cancer" in France: an economists' point of view].
Moatti JP; Le Corroller Soriano AG; Protière C
Bull Cancer; 2003 Nov; 90(11):1010-5. PubMed ID: 14706906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
